In addition, it has proven extremely challenging to genetically manipulate human xenograft B-ALL samples both in vitro and in vivo, which limits our ability to perform RAD51B loss-of-function studies in near-haploid B-ALL. Here, RAD51B is linked to acute lymphoblastic leukemia.